Care for the 15 most prevalent types of cancer in the U.S. cost approximately $156.2 billion in 2018, according to a team researchers. The team also found that medication was the biggest expense and that medication expense for breast, lung, lymphoma and colorectal cancers incurred the most costs.

An international agreement to protect the ozone layer is expected to prevent 443 million cases of skin cancer and 63 million cataract cases for people born in the United States through the end of this century, according to new research. The research team developed a computer modeling approach that revealed the effect of the Montreal Protocol and subsequent amendments on stratospheric ozone, the associated reductions in ultraviolet radiation, and the resulting health benefits.

Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood brain tumor in laboratory studies, an international team of researchers.

Researchers have developed a new way to determine whether individual patients will respond to a specific cancer drug or not. This kind of test could help doctors to choose alternative therapies for patients who don’t respond to the therapies normally used to treat their cancer.

To understand the biological underpinnings of skin and hair pigmentation and related diseases such as albinism or melanoma, scientists and doctors need quantitative, three-dimensional information about the architecture, content and location of pigment cells. Researchers have developed a new technique that allows scientists to visualize every cell containing melanin pigment in 3D, in whole zebrafish.

Researchers identified a small RNA molecule called miR-766-5p that reduces expression of MYC, a critical cancer-promoting gene. This microRNA reduces levels of proteins CBP and BRD4, which are both involved in super-enhancer (SE) formation. SEs form in areas of DNA that can fuel MYC expression and tumor progression. This study provides strong evidence for developing miR-766-5p as a novel therapeutic to treat MYC-driven cancers.

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer’s disease, new research has found. The drug, Axitinib, inhibits growth of new blood vessels in the brain — a feature shared by both cancer tumors and Alzheimer’s disease. This hallmark represents a new target for Alzheimer’s therapies. Mice that underwent the therapy not only exhibited a reduction in blood vessels and other Alzheimer’s markers in their brains, they also performed remarkably well in tests designed to measure learning and memory.

Scientists are using a new mathematical tool to predict how combinations of genetic mutations cause different types of tumors.

Scientists have created mice with a hormone profile that causes growth and metastatic spread of implanted human breast tumors. Results show that the team created a new mouse breed, called NSG-Pro, that produces levels of human prolactin similar to those in patients with metastatic estrogen receptor-positive breast cancer.

A new study examined the development of a glioblastoma cancerous tumor in animal models with a normal immune system, in order to best simulate the development of the tumor in humans.

A team led by researchers  has profiled in unprecedented detail thousands of individual cells sampled from patients‘ brain tumors. The findings, along with the methods developed to obtain those findings, represent a significant advance in cancer research, and ultimately may lead to better ways of detecting, monitoring and treating cancers.

Despite smoking’s well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked. While scientists are still working to understand what spurs cancer in so-called ’never-smokers,‘ a study suggests that 78% to 92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patient’s tumor.

Researchers have mapped out how hundreds of mutations involved in two types of cancer affect the activity of proteins that are the ultimate actors behind the disease. The work points the way to identifying new precision treatments that may avoid the side effects common with much current chemotherapy.

Scientists have detailed the effects of copper cysteamine, a next-generation cancer photo-drug.

What makes pancreatic cancer so deadly is its covert and quick spread. Now, a ‚time machine‘ has shown a way to reverse the course of cancer before it spreads throughout the pancreas.

Researchers can now rapidly isolate and chemically characterize individual organelles within cells. The new technique tests the limits of analytical chemistry and rapidly reveals the chemical composition of organelles that control biological growth, development and disease.

Scientist have utilized so-called SNAP-tag technology to radioactively label cells in living organisms. In a proof-of-principle study they developed a SNAP-tag substrate equipped with the radioactive signal emitter fluorine-18 and used it to make tumor cells in the bodies of mice visible in PET images. The labeling method, already established in microscopy, opens up the prospect of studying cells with different imaging techniques and at different temporal stages — for example, when inflammation begins, continues and resolves again. This may help reveal more about how the functions of individual cells and entire organs are interconnected.

Cancer immunotherapy seeks to turn ‚cold‘ tumors into ‚hot‘ tumors — those that respond to immunotherapy — by awakening and enlisting the body’s own immune system.

A common mutation in gliomas sensitizes them to immunotherapy, a finding which researchers believe could have broader therapeutic implications for all glioma patients.

The immune system relies on cell surface tags to recognize cancer cells. Researchers discovered mice who ate high-fat diets produced less of these tags on their intestinal cells, suppressing the ability of immune cells to identify and eliminate intestinal tumors. The high-fat diet also reduced the presence of certain bacteria in the mice’s gut, which normally helps maintain the production of these tags.

Engineers developed a technique that allows them to measure the generation rate and half-life of circulating tumor cells (CTCs) in mice.

Known as pediatric radiation-induced high-grade gliomas (RIGs), this specific type of brain tumor is caused by cranial radiation therapy for other cancers, most often brain cancers. They account for nearly 4% of all childhood brain tumor deaths, but there have not been many studies on RIGs and how to treat them.

A new research study turns cancer scientists into molecular detectives, searching for clues for why certain cancers are able to spread and evolve by studying tissues collected within hours of death.

Previously published solar exposure guidelines for optimal vitamin D synthesis based on a study of skin samples may need to be revised.

Researchers have discovered the working mechanism of potential drug targets for various diseases such as cancer, rheumatoid arthritis, and even COVID-19. The findings uncover the inner workings of cell receptors that are involved in cancer progression and inflammatory diseases.